How to Get Enclomiphene: Prescription and Pharmacy Options

Enclomiphene is not approved by the U.S. Food and Drug Administration, which means you cannot walk into a retail pharmacy with a standard prescription and pick it up as a manufactured drug. Instead, most people in the United States obtain enclomiphene through compounding pharmacies that prepare it from bulk pharmaceutical ingredients, typically after getting a prescription from a urologist, endocrinologist, or one of the growing number of telehealth men’s health clinics. The path to getting it is straightforward once you understand the regulatory landscape, but the lack of FDA approval creates wrinkles in cost, insurance coverage, and quality assurance that are worth knowing about before you start.

Why Enclomiphene Is Not at Your Local Pharmacy

Enclomiphene citrate, once developed under the brand name Androxal, went through multiple rounds of FDA review for the treatment of secondary hypogonadism in men. The developer, Repros Therapeutics, submitted a New Drug Application more than once, but the FDA declined to approve it each time, citing concerns about the clinical trial program rather than the drug’s safety or efficacy per se. After Repros was acquired, the pursuit of FDA approval effectively stalled. Without that approval, no pharmaceutical manufacturer can market enclomiphene as a finished, labeled product in the United States.

This matters for practical reasons. When a drug lacks FDA approval, chain pharmacies like CVS and Walgreens do not stock it. Insurance companies will not cover it. And no one can legally advertise it as a treatment for a specific condition. But “not FDA-approved” does not mean “illegal.” Physicians retain the authority to prescribe medications that are legally compounded, and compounding pharmacies can prepare enclomiphene under the regulatory framework that governs compounded drugs. That framework is how most people end up getting it.

The Compounding Pharmacy Route

Compounding pharmacies are licensed facilities that mix medications from raw ingredients to fill individual prescriptions. They operate under state pharmacy boards and, in some cases, under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. A 503A pharmacy compounds patient-specific prescriptions based on a valid prescription from a licensed provider. A 503B outsourcing facility can produce larger batches without patient-specific prescriptions, though it is subject to more FDA oversight.

To get enclomiphene from a compounding pharmacy, you need a prescription. Your doctor writes a script specifying the dose, and the pharmacy prepares capsules (most commonly) using enclomiphene citrate powder. Turnaround time varies. Some compounding pharmacies ship nationwide, and many telehealth clinics have relationships with specific compounders that streamline the process. Expect to pay out of pocket: prices typically range from $30 to $120 per month depending on the dose and the pharmacy, though this fluctuates. Since insurance does not cover it, shopping around or asking your prescriber which compounder they recommend can save real money.

Quality is worth thinking about. Compounded medications are not subject to the same manufacturing standards as FDA-approved drugs. Reputable compounding pharmacies voluntarily submit to third-party testing or are accredited by the Pharmacy Compounding Accreditation Board (PCAB). If you are choosing a compounder, asking about third-party purity testing or PCAB accreditation is a reasonable step. The difference between a well-run compounding pharmacy and a sloppy one matters more for a compounded drug than for a mass-manufactured one, precisely because there is less regulatory oversight built in.

How Telehealth Clinics Have Changed Access

The most common way men now obtain enclomiphene is through telehealth platforms specializing in men’s health and hormone optimization. These clinics have proliferated since the early 2020s, and many of them offer enclomiphene as a core part of their treatment protocols for low testosterone. The typical process involves filling out a health questionnaire, getting blood work (either through the clinic’s partnered lab or by uploading recent results), having a video or asynchronous consultation with a licensed provider, and then receiving a prescription that the clinic sends to its affiliated compounding pharmacy. The medication ships to your door.

The convenience is genuine, but so are the trade-offs. Telehealth clinics vary enormously in quality. Some are staffed by board-certified urologists and endocrinologists who follow evidence-based protocols. Others use nurse practitioners or physician assistants with limited specialized training, prescribing enclomiphene as a near-default option for anyone with testosterone levels on the lower end of normal. Before committing, it is reasonable to ask who the prescribing provider is, what their credentials are, and whether they require follow-up blood work to monitor your response. A clinic that prescribes without follow-up labs is cutting corners.

Getting a Prescription Through a Traditional Doctor

You do not have to go the telehealth route. Any physician with prescribing authority can write a prescription for compounded enclomiphene. Urologists who specialize in male infertility or andrology are the most familiar with it, followed by reproductive endocrinologists and some general endocrinologists. If you already have a relationship with a urologist or endocrinologist, raising enclomiphene as an option is a reasonable conversation to have, especially if you have documented low testosterone and want to preserve fertility.

Some primary care physicians will prescribe it as well, though many are less familiar with the drug and may be uncomfortable writing a prescription for a non-FDA-approved compound. If your PCP declines, a referral to urology or endocrinology is the standard next step. The clinical rationale for enclomiphene is strongest in men with secondary hypogonadism, meaning the issue is that the brain’s signaling to the testes is insufficient rather than the testes themselves being damaged. Your doctor will typically want to confirm this with blood work showing low or low-normal testosterone alongside LH levels that are not elevated.

What Enclomiphene Actually Does

Enclomiphene is one of two isomers found in clomiphene citrate (Clomid), a drug that has been prescribed for decades. Standard clomiphene contains roughly 62% enclomiphene (the trans-isomer) and 38% zuclomiphene (the cis-isomer). The two isomers behave differently. Enclomiphene acts as an estrogen receptor antagonist: it blocks estrogen from binding to receptors in the hypothalamus, which removes the brake on the brain’s signal to produce more luteinizing hormone and follicle-stimulating hormone. Those hormones then stimulate the testes to produce more testosterone.

Zuclomiphene, by contrast, has mixed estrogenic and anti-estrogenic effects. Research in animal models showed that zuclomiphene acts as an estrogen agonist in terms of LH secretion, meaning it can actually mimic estrogen’s suppressive effects on LH release, while simultaneously acting as an antagonist for FSH secretion.¹ Zuclomiphene also has a much longer half-life, which means it accumulates in the body with repeated dosing. This accumulation is thought to be responsible for many of the side effects men experience on standard clomiphene, including visual disturbances, mood changes, and estrogenic symptoms. By isolating the enclomiphene isomer, the idea is to get the testosterone-boosting benefit without the problematic baggage of zuclomiphene.

Why People Choose Enclomiphene Over Testosterone Replacement

The central appeal is fertility preservation. Exogenous testosterone, whether injected, applied as a gel, or delivered through pellets, suppresses the brain’s production of LH and FSH. Without those hormones, the testes shrink and sperm production drops, often to zero. This is why testosterone replacement therapy effectively acts as a male contraceptive in many men. Enclomiphene works in the opposite direction: it increases LH and FSH, which means the testes ramp up both testosterone and sperm production simultaneously.

Clinical studies have borne this out. In one trial comparing enclomiphene to topical testosterone gel in obese men with low testosterone, enclomiphene maintained sperm concentrations in the normal range over the treatment period, while the testosterone gel group experienced a marked reduction in sperm production.² A separate study found that enclomiphene elevated sperm counts in all treated men at three and six months, with concentrations ranging from 75 to 334 million per milliliter, while testosterone gel failed to raise counts above 20 million per milliliter in most men.³

For men who want to have children now or in the future, or who simply want to avoid the testicular atrophy that comes with exogenous testosterone, enclomiphene is an attractive alternative. It also avoids some of the regulatory and practical hassles of testosterone: no injections, no sticky gels, no controlled substance scheduling. Enclomiphene is an oral capsule taken once daily.

How Well Does It Raise Testosterone?

In a pharmacokinetic study, men taking 25 mg of enclomiphene daily for six weeks reached a mean total testosterone of about 604 ng/dL, compared to roughly 500 ng/dL in men using transdermal testosterone gel. The difference between the two groups was not statistically significant, suggesting comparable testosterone restoration at that dose.⁴ The enclomiphene groups also showed significant increases in LH, confirming that the drug was working through its intended mechanism of restoring the body’s own hormonal signaling rather than bypassing it.⁵

Individual responses vary. Some men see their testosterone climb well above 600 ng/dL, while others with more severe hypothalamic dysfunction get a more modest bump. The degree of response partly depends on how functional the testes are: enclomiphene signals the brain to tell the testes to work harder, which only works if the testes can respond. Men with primary hypogonadism, where the testes themselves are damaged, will not benefit much from enclomiphene.

Typical Dosing

Most clinical trials tested enclomiphene at doses of 12.5 mg, 25 mg, and 50 mg daily.⁶ In current clinical practice, a common approach is to start at 6.25 mg daily, increase weekly as tolerated up to 25 mg daily, and potentially go to 50 mg if the biochemical response is inadequate.⁷ The dose is guided by follow-up blood work, typically checked four to six weeks after starting or adjusting. Your prescriber is looking at total testosterone, free testosterone, LH, FSH, estradiol, and sometimes a complete blood count.

Some telehealth clinics default to 12.5 mg or 25 mg without much titration. There is nothing necessarily wrong with this if follow-up labs are done, but the evidence suggests that individual dose needs vary enough that a one-size-fits-all approach will overshoot for some men and undershoot for others. If your testosterone comes back above your target range or your estradiol climbs uncomfortably, the dose should be adjusted down rather than adding more medications to manage side effects.

Monitoring and Side Effects

Because enclomiphene raises testosterone through the body’s own hormonal axis rather than replacing it externally, some of the monitoring concerns associated with testosterone replacement are less relevant. One study on clomiphene citrate (which includes enclomiphene) found that it significantly increased testosterone levels without changing PSA or hematocrit values, two markers that typically need close monitoring on testosterone replacement therapy.⁸ That said, regular lab work is still recommended because biochemical responses vary from person to person.

Side effects with enclomiphene tend to be milder than with standard clomiphene, though head-to-head long-term safety data remains limited. Existing studies have focused primarily on hormone levels and hormonal side effects, with researchers acknowledging that the long-term effects on bone health, sexual function, and body composition have not been thoroughly studied.⁹ Commonly reported side effects include headache, mild nausea, and occasionally emotional changes, though these are generally less frequent than the visual disturbances and mood swings associated with standard clomiphene. If you experience persistent visual symptoms on enclomiphene, that warrants an immediate conversation with your prescriber.

Why You Should Avoid Unregulated Sources

The combination of growing demand, no FDA-approved product, and a large online fitness community has created a thriving gray market for enclomiphene. Research chemical websites, overseas pharmacies, and underground labs all sell products labeled as enclomiphene, sometimes at very low prices. The risks here are real and not theoretical.

Products from unregulated sources may contain the wrong isomer (zuclomiphene or a mixture), the wrong dose, contaminants, or no active ingredient at all. There is no quality control, no recourse if the product is mislabeled, and no one monitoring you for adverse effects. The broader pattern is well documented in the post-cycle therapy world, where unsupervised use of selective estrogen receptor modulators and other hormonal agents is common among people recovering from anabolic steroid use.¹⁰ Without lab work to confirm what you are actually taking and what it is doing to your hormone levels, you are guessing. And hormonal manipulation based on guesswork can cause problems that take months to sort out.

If cost is the barrier to going through legitimate channels, it is worth noting that compounded enclomiphene is already relatively inexpensive compared to testosterone replacement. The monthly cost of enclomiphene through a compounding pharmacy is often less than a single month of testosterone gel at retail price. The savings from buying from an unregulated source are real but small relative to the risk.

Enclomiphene and Anti-Doping Rules

If you compete in any sport governed by the World Anti-Doping Agency, a national anti-doping organization, or a professional league with a drug-testing program, enclomiphene is almost certainly prohibited. Clomiphene, which includes enclomiphene as an isomer, is banned both in and out of competition by WADA, and its use is prohibited by both amateur and professional sporting leagues due to its potential to increase testosterone levels.¹¹ A therapeutic use exemption is theoretically possible but difficult to obtain for a non-FDA-approved drug when FDA-approved alternatives exist. If you are subject to drug testing, discuss this with your prescriber and your sport’s compliance office before starting.

Standard Clomiphene as a Backup Option

If you cannot access enclomiphene through a compounding pharmacy or find the process too cumbersome, standard clomiphene citrate (Clomid) is FDA-approved for female ovulatory dysfunction and widely prescribed off-label for men with low testosterone. It is available at every retail pharmacy with a prescription, covered by many insurance plans (though often requiring prior authorization for male patients), and costs very little. The trade-off is the zuclomiphene isomer and its associated side effects, but many men tolerate standard clomiphene well, particularly at lower doses like 25 mg every other day.

Some clinicians start patients on standard clomiphene first, and if side effects become an issue, switch to compounded enclomiphene. This is a pragmatic approach, particularly for men who want to try the general class of drug before committing to the slightly more complex logistics of compounded medication. It also provides a useful comparison point: if you feel noticeably better on enclomiphene than on standard clomiphene, the zuclomiphene component was likely contributing to your side effects. If you feel about the same, there may be no practical reason to pay more for the isolated isomer.

What to Expect at Your First Appointment

Whether you go through a telehealth clinic or an in-person specialist, the process generally follows the same steps. You will need baseline blood work, at minimum total testosterone (drawn in the morning, ideally before 10 a.m., on two separate occasions), LH, FSH, estradiol, prolactin, a metabolic panel, and a complete blood count. Some providers also check thyroid function and SHBG. If your testosterone is low and your LH is not elevated, you fit the profile for secondary hypogonadism, and enclomiphene is a reasonable option to discuss.

Your prescriber should also ask about symptoms, not just numbers. A testosterone level of 350 ng/dL with significant fatigue, low libido, and difficulty concentrating is a different clinical situation than the same number in someone who feels fine. The decision to treat should be driven by both the labs and how you are actually functioning. After starting enclomiphene, follow-up labs are typically drawn at four to six weeks to assess response and adjust the dose. Once stable, most providers recheck every three to six months.

One thing to keep in mind: enclomiphene works by pushing your body to produce more testosterone, and some men’s bodies resist that push or respond inconsistently. If your levels do not improve after an adequate trial at an appropriate dose, your prescriber should investigate further rather than simply increasing the dose indefinitely. The drug is a tool, not a guarantee, and its effectiveness depends on the underlying cause of your low testosterone being amenable to increased gonadotropin signaling.